| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,761,336 | 7,494,876 | 6,718,368 | 7,950,268 | | Cost of Revenue | 3,360,187 | 3,128,998 | 2,935,921 | 3,178,381 | | | Gross Profit | 4,401,149 | 4,365,878 | 3,782,447 | 4,771,887 | | | Operating Expenses | | Research Development | 675,736 | 670,206 | 650,743 | 731,631 | | Selling General and Administrative | 2,085,660 | 2,024,252 | 2,070,945 | 2,297,360 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,639,753 | 1,671,420 | 1,060,759 | 1,742,896 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,480,896) | 32,587 | 995,910 | (52,530) | | Earnings Before Interest And Taxes | 2,005,987 | 1,704,007 | 2,056,669 | 1,809,363 | | Interest Expense | 134,612 | 136,969 | 124,190 | 123,157 | | Income Before Tax | 1,871,375 | 1,567,038 | 1,932,479 | 1,686,206 | | Income Tax Expense | 391,008 | 278,933 | 493,842 | 296,483 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,480,367 | 1,288,105 | 1,438,637 | 1,389,723 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 146,503 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,480,367 | 1,288,105 | 1,438,637 | 1,536,226 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,480,367 | $1,288,105 | $1,438,637 | $1,536,226 |
|
1.23% Nasdaq 
0.01 (0.02%) 
Income Statement
